Ethicon targets biosurgery market with next | 合法醫療器材資訊網

2019年8月13日—Asmedicaltechnologyadvances,thesurgeon'stoolboxexpandstoincludemoreeffectiveproducts,suchasbiosurgerysealantsthatactively ...

On June 19, Ethicon, a subsidiary of Johnson & Johnson Medical Devices Companies, announced 510(k) clearances for its Vistaseal dual applicator, a tissue sealant product for use in open and laparoscopic surgery, and the first clearance since the company partnered with Spain-based Grifols, a leading provider of plasma-derived medicines worldwide.

Prompt hemostasis and effective incision closure have been major concerns for surgeons. As medical technology advances, the surgeon’s toolbox expands to include more effective products, such as biosurgery sealants that actively stop bleeding in cases where the application of pressure, ligature, and other conventional methods are ineffective.

Tissue sealants are associated with higher success rates, ease of operation, shorter recovery times, and higher patient satisfaction. Vistaseal is Ethicon’s next-generation airless spray device that combines biologics with device technology.

Although high costs, weak reimbursement, ...